FDA Center for Drug Evaluation & Research Issues Warning Letter to Auriga Research
August 19, 2026
August 19, 2026
WASHINGTON, Aug. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Auriga Research Pvt. Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Dr. Saurabh Arora, Managing Director and CEO, Auriga Research Pvt. Ltd., 3/17 Kirti Nagar, Industrial Area, New Delhi 110015, India, (b)(4)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
* * *
Recipient: Dr. Saurabh Arora, Managing Director and CEO, Auriga Research Pvt. Ltd., 3/17 Kirti Nagar, Industrial Area, New Delhi 110015, India, (b)(4)
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
